In this study, activation of PTEN signaling identified in Stages I and II, but not Stages IIIC and IV compared to the Benign groups may be due to the higher association of diabetes with early stage or Type I endometrial cancer compared to late stage or Type II endometrial cancer. The gene discussed is PTEN; the disease is diabetes mellitus.